Medical News

RSS

Smith & Nephew adds PELNAC dermal replacement wound product to its portfolio

Smith & Nephew (LSE: SN) Advanced Wound Management division, announces the agreement to partner with Gunze Limited, Japan and exclusively distribute PELNAC dermal replacement in Japan, South Africa, Australia and New Zealand.

24 Dec 2009

Michele Obama visits Children's National Medical Center

First Lady Michelle Obama read the holiday classic 'Twas the Night before Christmas by Clement Clarke Moore, during her holiday visit to Children's National Medical Center.

24 Dec 2009

CPF, ATS and health groups launch campaign to raise awareness on lung health

The Coalition for Pulmonary Fibrosis (CPF) announced today it is joining with the American Thoracic Society (ATS) and lung health organizations around the globe for 2010: The Year of the Lung, a multi-faceted campaign that aims to raise awareness about the importance of lung health, generate social and political support for preventing and treating lung disease and encouraging increased public and private funding for lung disease research and development.

24 Dec 2009

Oklahoma's largest health insurer redesigns web site

Because Blue Cross and Blue Shield of Oklahoma recognizes that health insurance is becoming more and more complicated, the state's largest health insurer has redesigned its public Web site to better assist and educate customers as well as the general public. Now live, the new site provides an education that enables wise health care decisions, communicates a commitment to partnership with Blue Cross and Blue Shield of Oklahoma customers and emphasizes the insurer's trustworthiness.

24 Dec 2009

Teva-KOWA Pharma signs definitive agreement to acquire major shares in Taisho Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. announced today that Teva-KOWA Pharma Co., Ltd., the Company's joint venture in Japan with KOWA Company, Ltd., has signed a definitive agreement to acquire a majority of the outstanding shares of Taisho Pharmaceutical Industries, Ltd.

24 Dec 2009

Terri McCormick's statement on Senate healthcare reform bill

In the rush to pass the so-called "healthcare reform bill," U.S. Senator Ben Nelson (D-NE) stomped his feet and held his breath until he extracted his presents from Senate Majority Leader Harry Reid. One such gift exempts Nebraska from paying the $45 million increase in Medicaid imbursement costs. Nelson was the 60th Democrat to get his stocking stuffed.

24 Dec 2009

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.

24 Dec 2009

Data compares non-group health insurance and COBRA premiums

Today, eHealthInsurance.com (NASDAQ: EHTH), the leading online source of health insurance for individuals, families and small businesses, released data comparing non-group health insurance premiums for policies available at eHealth in the state of California, and subsidized COBRA premiums for people in California.

24 Dec 2009

Growing public health threat from surge in drug-resistant strains of acinetobacter

A new study in the journal Infection Control and Hospital Epidemiology reports a surge in drug-resistant strains of Acinetobacter, a dangerous type of bacteria that is becoming increasingly common in U.S. hospitals. This study is being posted online today and will appear in the journal's February print edition.

24 Dec 2009

Oxford Outcomes becomes a member of SAFE-BioPharma Association

Oxford Outcomes, an international health outcomes consultancy, has become a member of SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.

24 Dec 2009

Celsius Holdings announces implementation of 1 for 20 reverse stock split

Celsius Holdings, Inc. will implement its previously announced 1 for 20 reverse stock split at the close of business on December 23, 2009. Upon the effectiveness of the reverse stock split, all our issued and outstanding shares of common stock will be combined and reconstituted as a smaller number of shares of common stock, in a ratio of one share of common stock for every 20 shares of common stock.

24 Dec 2009

Study suggests routine evaluation does not predict prostate cancer

On the heels of the American Cancer Society's recent controversial response to breast and prostate cancer screenings guidelines, a new study from the Mayo Clinic has emerged analyzing the correlation between prostate-specific antigen (PSA) levels and prostate size. The study discovered that routine annual evaluation of prostate growth does not predict the development of prostate cancer.

24 Dec 2009

U.S. Bankruptcy Court grants TLC Vision relief requested in its "First Day Motions"

TLC Vision Corporation, North America's premier eye care services company, today announced that further to its press release issued on December 21, 2009, the United States Bankruptcy Court for the District of Delaware has granted the relief the Company and two of its wholly-owned subsidiaries, TLC Vision (USA) Corporation and TLC Management Services Inc., requested in its "First Day Motions" filed in conjunction with its voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code.

24 Dec 2009

Study reveals genomic switches separate autoimmune disorders in different clusters

Genomic switches can predispose an individual to one set of autoimmune disorders but protect the same person against another set of them, scientists at Stanford University School of Medicine have found.

24 Dec 2009

Key molecular switch linked to HD identified

Scientists have identified a key molecular switch that may drive the onset of Huntington's disease (HD), an incurable neurodegenerative disorder that leads to severe disruptions in muscle coordination and cognitive function. The research, published by Cell Press in the December 24 issue of the journal Neuron, enhances the understanding of HD pathogenesis and may direct new strategies for treating this devastating brain disease.

24 Dec 2009

Potential new therapeutic option for prevention of PD-associated neuropathology

Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.

24 Dec 2009

Tips to minimize injuries during winter season

As we try to get outside and make the most of these cold winter months, it's important to use basic safety tips that help minimize injury. The Minnesota Chiropractic Association (MCA) offers the following tips to help keep your family injury free.

24 Dec 2009

Stem Cell Therapy International-Histostem merger on schedule

Stem Cell Therapy International, Inc. announced that its pre-closing conditions for its merger with Histostem Co. Ltd. ("Histostem") are proceeding on schedule with an expected close of the merger in January 2010.

24 Dec 2009

Transcend Services closes public offering of common stock

TRANSCEND SERVICES, INC. (the “Company”) today announced the December 22, 2009 closing of the public offering of a total of 2,553,000 shares of its common stock at a price to the public of $16.75 per share. The Company sold 1,725,000 shares and the selling stockholders sold 828,000 shares.

24 Dec 2009

Drug companies winners of the American prescription drug debate

On Dec. 15, the Obama Administration rejected a plan to allow the wholesale reimportation of cheaper prescriptions drugs from abroad, despite projected intentions to take on the drug industry and secure cheaper prescription for Americans.

24 Dec 2009